Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (69)

« Back to Publications

High prevalence of MASLD in psoriasis and psoriatic arthritis assessed with multiparametric magnetic resonance imaging.

James L. et al, (2025), Rheumatology (Oxford), 64, 5741 - 5750

Inhibition of cell-mediated immunity in type 1 diabetes by beta cell-targeted PD-1 agonists in pancreas tissue slices.

Becker MW. et al, (2025)

Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL-17 treatment: a clinical case.

James L. et al, (2025), Rheumatology (Oxford), 64, 4425 - 4427

Liver fibro-inflammation in psoriatic arthritis with MASLD improved by anti-IL17 treatment: a clinical case

James L. et al, (2025), Rheumatology, 64, 4425 - 4427

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial.

Worth C. et al, (2024), Lancet Rheumatol, 6, e537 - e545

Genetic determinants of monocyte splicing are enriched for disease susceptibility loci including for COVID-19

Fairfax B. et al, (2024)

Granulocyte-macrophage colony-stimulating factor neutralisation in patients with axial spondyloarthritis in the UK (NAMASTE): a randomised, double-blind, placebo-controlled, phase 2 trial

Jones C. et al, (2024), Lancet Rheumatology, 6, E537 - E545

Elevated type-17 cytokines are present in axial spondyloarthritis stool.

Brough I. et al, (2024), Discov Immunol, 3

Optimising psoriatic arthritis therapy with immunological methods to increase standard evaluation: the protocol of an open-label multicentre, parallel-group, two-arm randomised controlled study evaluation precision medicine approach in the treatment of psoriatic arthritis.

Ooms A. et al, (2023), BMJ Open, 13

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates.

Simone D. et al, (2021), Commun Biol, 4

Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid.

Yager N. et al, (2021), Ann Rheum Dis, 80, 1559 - 1567

irst in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study)

Al-Mossawi M. et al, (2021), Clinical and Experimental Rheumatology, 39, 1161 - 1161

Single cell analysis of spondyloarthritis regulatory T cells identifies distinct synovial gene expression patterns and clonal fates

Simone D. et al, (2021), Annals of the Rheumatic Diseases, 80, 17 - 18

Ex vivo mass cytometry analysis reveals a profound myeloid proinflammatory signature in psoriatic arthritis synovial fluid

Yager N. et al, (2021), bioRxiv

PROINFLAMMATORY OSTEOPONTIN AND CCL2 ARE SPONTANEOUSLY PRODUCED BY PSORIATIC ARTHRITIS SYNOVIAL MYELOID CELLS

Yager N. et al, (2021), CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 39, 1212 - 1212

Load More

1
2
3
4
5